Patents by Inventor Glenn H. Berman

Glenn H. Berman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10010291
    Abstract: A system and method provides a glucose report for determining glycemic risk based on an ambulatory glucose profile of glucose data over a time period, a glucose control assessment based on median and variability of glucose, and indicators of high glucose variability. Time of day periods are shown at which glucose levels can be seen. A median glucose goal and a low glucose line provide coupled with glucose variability provide a view into effects that raising or lowering the median goal would have. Likelihood of low glucose, median glucose compared to goal, and variability of glucose below median provide probabilities based on glucose data. Patterns can be seen and provide guidance for treatment.
    Type: Grant
    Filed: March 15, 2014
    Date of Patent: July 3, 2018
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Erwin S. Budiman, Gary A. Hayter, Kenneth J. Doniger, Timothy C. Dunn, Nathan C. Crouther, Glenn H. Berman, Howard A. Wolpert
  • Publication number: 20160034658
    Abstract: Methods and systems for validating safety critical applications (SCAs) on uncontrolled data processing devices (UDPDs) are provided. Various combinations of checks including validation of safety critical features, validation of SCA-UDPD compatibility, and resource management are executed at various times to ensure the SCA operates properly on the device. The operation of the SCA on the UDPD may be controlled accordingly.
    Type: Application
    Filed: July 30, 2015
    Publication date: February 4, 2016
    Inventors: Glenn H. Berman, Hung Dinh, Michael R. Love, Mark K. Sloan
  • Publication number: 20140350369
    Abstract: A system and method provides a glucose report for determining glycemic risk based on an ambulatory glucose profile of glucose data over a time period, a glucose control assessment based on median and variability of glucose, and indicators of high glucose variability. Time of day periods are shown at which glucose levels can be seen. A median glucose goal and a low glucose line provide coupled with glucose variability provide a view into effects that raising or lowering the median goal would have. Likelihood of low glucose, median glucose compared to goal, and variability of glucose below median provide probabilities based on glucose data. Patterns can be seen and provide guidance for treatment.
    Type: Application
    Filed: March 15, 2014
    Publication date: November 27, 2014
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Erwin S. Budiman, Gary A. Hayter, Kenneth J. Doniger, Timothy C. Dunn, Nathan C. Crouther, Glenn H. Berman, Howard A. Wolpert